Whole-exome sequencing (WES) using next-generation sequencing (NGS) technology is a powerful tool for investigating variants linked to genetic disease. It…

Next-generation sequencing (NGS) techniques allow high-throughput detection of a vast amount of genetic variations in a cost-effective manner. However, there…

The Winter 2020 Release of the Human Gene Mutation Database (HGMD) Professional is available, expanding the world’s largest collection of…

Discover more about the latest QCI update and how the platform simplifies and accelerates NGS variant analysis, interpretation, and reporting…

Today genetic innovation is advancing at breakneck pace. Since the first whole genome was sequenced in 2003, a feat that…

We are excited to announce the general availability of the Fall 2020 Release of QIAGEN Clinical Insight (QCI) Interpret. This…

The Human Gene Mutation Database (HGMD®) Professional has over 298,000 inherited disease-relevant mutations and polymorphisms–nearly 40% more than in the…

The Fall 2020 Release of the Human Gene Mutation Database (HGMD) Professional is available, expanding the world’s largest collection of…

When it comes to the digital transformation of healthcare, it isn’t just about technology – it is about how digital…

We’re pleased to announce that our newest clinical NGS variant interpretation and reporting solution is now available in Europe.  …

Introducing a new login portal QIAGEN Digital Insights is introducing a new login URL  to access HGMD, ANNOVAR, Genome Trax,…

How pharmaceutical companies can leverage real-world genomic data to overcome inefficiencies in cancer drug development In the June 2020 issue…